POLETTO, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 236
EU - Europa 159
AS - Asia 110
AF - Africa 2
Totale 507
Nazione #
US - Stati Uniti d'America 234
IT - Italia 105
SG - Singapore 80
IE - Irlanda 13
CN - Cina 12
SE - Svezia 9
ID - Indonesia 8
FI - Finlandia 6
FR - Francia 6
ES - Italia 4
GB - Regno Unito 4
VN - Vietnam 4
DE - Germania 3
KR - Corea 3
CA - Canada 2
CH - Svizzera 2
NG - Nigeria 2
AZ - Azerbaigian 1
GR - Grecia 1
LU - Lussemburgo 1
NL - Olanda 1
NO - Norvegia 1
PL - Polonia 1
PT - Portogallo 1
SA - Arabia Saudita 1
SI - Slovenia 1
TW - Taiwan 1
Totale 507
Città #
Singapore 71
Santa Clara 68
Chandler 19
Turin 17
Dublin 13
Fairfield 13
Columbus 12
Ashburn 11
Genoa 8
Jakarta 8
Milan 6
Nyköping 5
Torino 5
Madrid 4
Medford 4
Princeton 4
Wilmington 4
Woodbridge 4
Ann Arbor 3
Beijing 3
Cambridge 3
Genova 3
Helsinki 3
Houston 3
Lappeenranta 3
Padova 3
Prineville 3
San Diego 3
Seoul 3
Upper Marlboro 3
Abuja 2
Collegno 2
Croydon 2
Formello 2
Hangzhou 2
Hebei 2
Jacksonville 2
Marcon 2
Nichelino 2
Salerno 2
Villanova D'asti 2
Wuhan 2
Baku 1
Bari 1
Calci 1
Cardiff 1
Falkirk 1
Florence 1
Ivry-sur-seine 1
Lausanne 1
Lisbon 1
Luxembourg 1
Modena 1
Montréal 1
Nanchang 1
New Castle 1
Nova Gorica 1
Nuremberg 1
Palermo 1
Paris 1
Riverton 1
Rosasco 1
Salzano 1
San Mateo 1
Seattle 1
Silea 1
Stavanger 1
Taipei 1
Tivoli 1
Toronto 1
Zurich 1
Totale 365
Nome #
Melanoma Brain Metastases in the Era of Target Therapies: An Overview 121
Post-Transplant Cyclophosphamide and Tacrolimus-Mycophenolate Mofetil Combination Governs GVHD and Immunosuppression Need, Reducing Late Toxicities in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors 106
High BRAF variant allele frequencies are associated with distinct pathological features and responsiveness to target therapy in melanoma patients 58
Current Controversies and Challenges on BRAF V600K-Mutant Cutaneous Melanoma 39
How to Improve the Quality of Life of Patients with Prostate Cancer Treated with Hormone Therapy? 37
CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma 30
Treatment strategies for patients with diffuse large B-cell lymphoma 23
Synthetic Lethality by Co-Inhibition of Androgen Receptor and Polyadenosine Diphosphate-Ribose in Metastatic Prostate Cancer 23
Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma Intergroup 20
Predictive Factors in Metastatic Melanoma Treated with Immune Checkpoint Inhibitors: From Clinical Practice to Future Perspective 18
Impact of Neuroendocrine Differentiation (NED) on Enzalutamide and Abiraterone Efficacy in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Retrospective Analysis 17
Hormonal Agents in Localized and Advanced Prostate Cancer: Current Use and Future Perspectives 13
From Cancer to Immune Organoids: Innovative Preclinical Models to Dissect the Crosstalk between Cancer Cells and the Tumor Microenvironment 13
Role of osimertinib plus brain radiotherapy versus osimertinib single therapy in EGFR-mutated Non-Small-Cell Lung Cancer with brain metastases: a meta-analysis and systematic review 9
Totale 527
Categoria #
all - tutte 2.687
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.687


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202162 4 3 7 0 0 6 2 9 5 7 5 14
2021/202280 12 2 6 8 7 5 3 3 2 8 11 13
2022/202393 7 11 4 5 2 13 13 13 7 0 11 7
2023/202480 4 11 5 1 2 9 9 7 6 7 6 13
2024/2025212 0 35 20 31 94 32 0 0 0 0 0 0
Totale 527